Vérification…
Traduit automatiquement. Doses et mises en garde : vérifiez l'original en anglais. Lire en anglais
Accueil / Enregistré au Nigeria / Histolat Syrup

Histolat Syrup

NAFDAC REG NO: A11-100023 Médicament

Enregistré auprès de NAFDAC. Enregistrement actifAs of 5 November 2026 · synced automatically from official sources.
Produit
Histolat Syrup
Numéro NAFDAC
A11-100023
Principe actif
Levocetirizine Dihydrochloride
Dosage
2.5 mg/5 mL
Forme
Syrup
Conditionnement
1 x 60 mL (in amber PET bottle)
Fabricant
Non répertorié
Déposant / Titulaire :
Afrab-Chem Limited
Approuvé
29 Mar 2021
Statut
Inactive Vue sur NAFDAC ↗
Enregistrement valable jusqu'au
28 Mar 2026
Alertes OMS
Non trouvé
Community reports
None
Times checked
0

About the medicine: Levocetirizine dihydrochloride: uses, dosage and brands worldwide

What we found

  • Histolat Syrup is on the NAFDAC register with an active registration (A11-100023). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Histolat Syrup

Ce que dit la notice officielle. Si un médecin vous l'a prescrit, suivez l'ordonnance. La notice de votre boîte prime si elle est différente.

Pour qui

Temporarily relieves these symptoms due to hay fever or other respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat

Comment le prendre et à quelle fréquence
  • Adults 65 years of age and older ask a doctor
  • Adults and children 12-64 years of age take 1 tablet (5 mg) once daily in the evening
  • Do not take more than 1 tablet (5 mg) in 24 hours 1/2 tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms
  • Children 6-11 years of age take 1/2 tablet (2.5 mg) once daily in the evening
  • Do not take more than 1/2 tablet (2.5 mg) in 24 hours
  • Children under 6 years of age do not use consumers with kidney disease do not use
While you are taking it

drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery

Talk to a doctor first if

ever had trouble urinating or emptying your bladder

Warnings

Do not use if you have kidney disease if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine Ask a doctor before use if you have ever had trouble urinating or emptying your bladder When using this product drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery Stop use and ask doctor if you have trouble urinating or emptying your bladder an allergic reaction to this product occurs. Seek medical help right away. …

Effets secondaires possibles

Stop use and ask doctor if you have trouble urinating or emptying your bladder an allergic reaction to this product occurs. Seek medical help right away.

Pregnancy and breastfeeding

If pregnant or breast-feeding: if breast-feeding: not recommended if pregnant: ask a health professional before use

How to store it

Keep out of reach of children.

En cas d'oubli

Prenez-le dès que vous y pensez, sauf s'il est presque l'heure de la dose suivante. Dans ce cas, sautez la dose oubliée. Ne prenez jamais deux doses à la fois pour compenser. Vérifiez votre notice, certains médicaments font exception.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2025-12-10.

Label for levocetirizine dihydrochloride, the active ingredient registered with NAFDAC.

Check your pack of Histolat Syrup

Add the expiry date on your pack for a full Trust Score.

Ou prenez la boîte en photo
Encore 3 vérifications gratuites aujourd'hui Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

About Histolat Syrup

What is in Histolat Syrup?

Histolat Syrup contains Levocetirizine Dihydrochloride (2.5 mg/5 mL), as syrup, according to its NAFDAC registration record.

Is Histolat Syrup registered with NAFDAC?

Yes. Histolat Syrup is listed on the NAFDAC register under registration number A11-100023, and its registration is active as of 5 November 2026.

Has Histolat Syrup been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Histolat Syrup in our automatically synced alert list.

How can I check that my pack of Histolat Syrup is genuine?

Run a free authenticity scan with the NAFDAC number A11-100023, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Histolat Syrup?

Follow your prescription or the leaflet in your pack. The official label says: adults 65 years of age and older ask a doctor adults and children 12-64 years of age take 1 tablet (5 mg) once daily in the evening do not take more than 1 tablet (5 mg) in 24 hours 1/2 tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms children 6-11 years of age take 1/2 tablet (2.5 mg) once daily in the evening do not take more than 1/2 tabl…

What is Histolat Syrup used for?

temporarily relieves these symptoms due to hay fever or other respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat (Summarised from the official U.S. FDA label for levocetirizine dihydrochloride. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Histolat Syrup? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.